Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.48 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.47 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.45 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | PDE9A | O76083 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2964464 | 1.00 | ESR1 (0.50) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL21238074 | 0.96 | ESR1 (0.52) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL19720301 | 0.96 | ESR1 (0.52) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL18880023 | 0.94 | CYP1B1 (0.48) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL259152 | 0.94 | ESR1 (0.50) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL29375861 | 0.94 | ESR1 (0.50) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL15366790 | 0.92 | ESR1 (0.47) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL28538557 | 0.92 | ESR1 (0.49) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL27367720 | 0.92 | ESR1 (0.52) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL3867431 | 0.91 | ESR1 (0.48) | ESR1ESR2ALOX5HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2388843-B1 | Organic material and organic light emitting diode display using same | SAMSUNG DISPLAY CO LTD (KR) | 2019-08-07 | — | — | EP | disclosed |
| EP-2183799-B1 | HIGH-PERFORMANCE BROADBAND OLED DEVICE | GLOBAL OLED TECHNOLOGY LLC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-9634254-B2 | Organic material and organic light emitting diode display using same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-04-25 | — | — | US | disclosed |
| US-8134035-B2 | Preparation of asymmetric anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2012-03-13 | — | — | US | disclosed |
| US-20110285274-A1 | ORGANIC MATERIAL AND ORGANIC LIGHT EMITTING DIODE DISPLAY USING SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-11-24 | — | — | US | disclosed |
| EP-2388843-A2 | Organic material and organic light emitting diode display using same | Samsung Mobile Display Co., Ltd. (KR) | 2011-11-23 | — | — | EP | disclosed |
| US-8042023-B2 | Memory system with cyclic redundancy check | QIMONDA AG (DE) | 2011-10-18 | — | — | US | disclosed |
| US-20110065924-A1 | PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-17 | — | — | US | disclosed |
| EP-2183799-A1 | HIGH-PERFORMANCE BROADBAND OLED DEVICE | Global OLED Technology LLC (US) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009025724-A1 | HIGH-PERFORMANCE BROADBAND OLED DEVICE | EASTMAN KODAK COMPANY (US) | 2009-02-26 | — | — | WO | disclosed |
| US-20090053559-A1 | HIGH-PERFORMANCE BROADBAND OLED DEVICE | GLOBAL OLED TECHNOLOGY LLC | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110285274-A1 | ORGANIC MATERIAL AND ORGANIC LIGHT EMITTING DIODE DISPLAY USING SAME | OCIAD1, OCIAD2, DRD1 | ESR1 177/4885ESR2 944/4885ALOX5 445/4885 |
| US-20110065924-A1 | PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | AKR7A2, ACMSD, ALKBH3 | ESR1 1053/4885ESR2 1080/4885ALOX5 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.